Loading...
Olaparib
India Pharmaceutical Trade Intelligence
Who Supplies Olaparib to India from CANADA
India's olaparib imports from CANADA total $194.1K across 17 shipments from 8 foreign suppliers. M/S. DELUXE HEALTH GROUP INC. leads with $104.6K in import value; the top 5 suppliers together control 87.7% of this origin. Leading Indian buyers include NATCO PHARMA LIMITED. This corridor reflects India's pharmaceutical import demand for olaparib — a diversified sourcing base with multiple active suppliers from CANADA.
Top foreign suppliers (CANADA) — Ranked by import value
M/S. DELUXE HEALTH GROUP INC. is the leading Olaparib supplier from CANADA to India, with import value of $104.6K across 2 shipments. The top 5 suppliers — M/S. DELUXE HEALTH GROUP INC., GENVION CORPORATION, ACCORD HEALTHCARE INC, NEWLIFE MEDICALS (USA).INC., ESPEE BIOPHARMA & FINECHEM LLC — collectively account for 87.7% of total import value from this origin.
Top foreign suppliers (CANADA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | M/S. DELUXE HEALTH GROUP INC. | $104.6K | 2 | 53.9% |
| 2 | GENVION CORPORATION | $35.0K | 5 | 18.0% |
| 3 | ACCORD HEALTHCARE INC | $12.7K | 2 | 6.5% |
| 4 | NEWLIFE MEDICALS (USA).INC. | $9.0K | 2 | 4.7% |
| 5 | ESPEE BIOPHARMA & FINECHEM LLC | $8.9K | 2 | 4.6% |
| 6 | DELUXE HEALTH GROUP INC. | $8.5K | 1 | 4.4% |
| 7 | TARO PHARMACEUTICALS INC. | $7.8K | 2 | 4.0% |
| 8 | ADIRA MEDICA INC. | $7.6K | 1 | 3.9% |
Showing top 8 of 8 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from CANADA)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NATCO PHARMA LIMITED | $113.1K | 3 | 58.3% |
| 2 | CIPLA LIMITED | $44.0K | 7 | 22.7% |
| 3 | DR.REDDY'S LABORATORIES LIMITED | $16.5K | 3 | 8.5% |
| 4 | INTAS PHARMACEUTICALS LIMITED | $12.7K | 2 | 6.5% |
| 5 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $7.8K | 2 | 4.0% |
Import Statistics
- Import Value
- $194.1K
- Shipments
- 17
- Foreign Suppliers
- 8
- Indian Buyers
- 5
- Avg. Shipment
- $11.4K
Other Olaparib Import Origins
Frequently Asked Questions — Olaparib Imports from CANADA
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Olaparib suppliers from CANADA to India?
The top Olaparib suppliers from CANADA to India include M/S. DELUXE HEALTH GROUP INC., GENVION CORPORATION, ACCORD HEALTHCARE INC. The leading supplier is M/S. DELUXE HEALTH GROUP INC. with import value of $104.6K USD across 2 shipments. India imported Olaparib worth $194.1K USD from CANADA in total across 17 shipments.
QHow much Olaparib does India import from CANADA?
India imported Olaparib worth $194.1K USD from CANADA across 17 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Olaparib from CANADA?
The main Indian buyers of Olaparib sourced from CANADA include NATCO PHARMA LIMITED, CIPLA LIMITED, DR.REDDY'S LABORATORIES LIMITED. The largest buyer is NATCO PHARMA LIMITED with $113.1K in imports across 3 shipments.
QWhat is the total value of Olaparib imports from CANADA to India?
The total value of Olaparib imports from CANADA to India is $194.1K USD, across 17 shipments and 8 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: CANADA to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Olaparib.
- 2.Supplier/Buyer Matching: 8 foreign suppliers from CANADA and 5 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $194.1K aggregated from 17 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
17 Verified Shipments
8 suppliers, 5 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists